University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Pharmacogenetics of Hypertriglyceridemia in Hispanics

Completed

Conditions: Heart Diseases
Cardiovascular Diseases
Hypertriglyceridemia

First Posted Date: 2004-07-05

Last Posted Date: 2015-12-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 274

Registration Number: NCT00086437

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Phase 3

Completed

Conditions: Opioid-Related Disorders

First Posted Date: 2004-02-20

Last Posted Date: 2017-01-12

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 516

Registration Number: NCT00078117

Locations: 🇺🇸
Hartford Dispensary, Hartford, Connecticut, United States
🇺🇸
Connecticut Counseling Centers, Waterbury, Connecticut, United States
🇺🇸
LI Jewish Health System, Glen Oaks, New York, United States

and more 8 locations

Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis

Not Applicable

Completed

Conditions: Rheumatoid Arthritis

Interventions: Behavioral: Cognitive Behavioral Therapy
Behavioral: Tai Chi Chih
Behavioral: Health Education Seminar

First Posted Date: 2003-11-10

Last Posted Date: 2013-04-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 106

Registration Number: NCT00072657

Locations: 🇺🇸
Cousins Center for Psychoneuroimmunology, UCLA, Los Angeles, California, United States

Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs

Not Applicable

Completed

Conditions: Dementia
Alzheimer Disease

First Posted Date: 2003-07-18

Last Posted Date: 2020-03-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 138

Registration Number: NCT00065169

Locations: 🇺🇸
UCLA Neuropsychiatric Institute, Los Angeles, California, United States

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Other: placebo
Drug: celecoxib

First Posted Date: 2003-03-07

Last Posted Date: 2011-06-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 112

Registration Number: NCT00055978

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Online Family Support and Education for Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Behavioral: Online Family Education
Behavioral: Customary care

First Posted Date: 2002-09-23

Last Posted Date: 2016-09-09

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 42

Registration Number: NCT00046085

Locations: 🇺🇸
VA Greater Los Angeles Healthcare System, Los Angeles, California, United States

Early Surgical Intervention to Treat Epilepsy

Phase 3

Completed

Conditions: Epilepsy
Epilepsy, Temporal Lobe
Seizures

Interventions: Drug: antiepileptic drugs
Procedure: anteromesial temporal resection

First Posted Date: 2002-06-25

Last Posted Date: 2010-02-23

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 200

Registration Number: NCT00040326

Locations: 🇺🇸
University of Michigan, Department of Neurology, Ann Arbor, Michigan, United States
🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 9 locations

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Phase 3

Completed

Conditions: Heroin Dependence
Morphine Dependence
Substance Withdrawal Syndrome

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-12

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 341

Registration Number: NCT00032968

Locations: 🇺🇸
Midtown Community Mental Health Center, Indianapolis, Indiana, United States
🇺🇸
Aegis Medical Systems, Inc., Oxnard, California, United States
🇺🇸
Haight-Ashbury Free Clinic, Berkeley, California, United States

and more 4 locations

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

Phase 3

Completed

Conditions: Heroin Dependence
Morphine Dependence
Substance Withdrawal Syndrome

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-12

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 163

Registration Number: NCT00032955

Locations: 🇺🇸
Phoenix House, New York, New York, United States
🇺🇸
Betty Ford Center, Rancho Mirage, California, United States
🇺🇸
The Center For Drug-Free Living, Orlando, Florida, United States

and more 3 locations

Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial

Phase 3

Completed

Conditions: Memory Disorders

First Posted Date: 2001-01-24

Last Posted Date: 2020-03-02

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT00009230

Locations: 🇺🇸
UCLA Neuropsychiatric Institute, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy